期刊
CELL REPORTS
卷 30, 期 5, 页码 1310-+出版社
CELL PRESS
DOI: 10.1016/j.celrep.2019.12.092
关键词
-
类别
资金
- National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health of the United States [R01DK119386]
- NIDDK [P30-34989]
Pathological activation of TGF-beta signaling is universal in fibrosis. Aberrant TGF-beta signaling in conjunction with transdifferentiation of hepatic stellate cells (HSCs) into fibrogenic myofibroblasts plays a central role in liver fibrosis. Here we report that the DNA demethylase TET3 is anomalously upregulated in fibrotic livers in both humans and mice. We demonstrate that in human HSCs, TET3 promotes profibrotic gene expression by upregulation of multiple key TGF-beta pathway genes, including TGFB1. TET3 binds to target gene promoters, inducing demethylation, which in turn facilitates chromatin remodeling and transcription. We also reveal a positive feedback loop between TGF-beta 1 and TET3 in both HSCs and hepatocytes. Furthermore, TET3 knockdown ameliorates liver fibrosis in mice. Our results uncover a TET3/TGF-beta 1 positive feedback loop as a crucial determinant of liver fibrosis and suggest that inhibiting TET3 may represent a therapeutic strategy for liver fibrosis and perhaps other fibrotic diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据